Plasmapheresis of the patient as a method for achieving effective levels of plasma coagulation factors using fresh frozen plasma.
作者信息
Perkins H A
出版信息
Transfusion. 1966 Jul-Aug;6(4):293-301. doi: 10.1111/j.1537-2995.1966.tb04742.x.
Abstract
摘要
相似文献
1
Plasmapheresis of the patient as a method for achieving effective levels of plasma coagulation factors using fresh frozen plasma.
Transfusion. 1966 Jul-Aug;6(4):293-301. doi: 10.1111/j.1537-2995.1966.tb04742.x.
2
Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.
Br Med J. 1967 Apr 8;2(5544):88-91. doi: 10.1136/bmj.2.5544.88.
3
Orthotopic liver transplantation in a patient with combined hemophilia A and B.
Am J Hematol. 1990 Feb;33(2):136-8. doi: 10.1002/ajh.2830330211.
4
[Transfusion therapy of hemophilia A and B].
Bibl Haematol. 1967;27:204-10.
5
Therapy for AHF and PTC hemophilia. I.
IMJ Ill Med J. 1970 May;137(5):518-21.
6
[Treatment of hemophilia].
Dtsch Med Wochenschr. 1969 Sep 12;94(37):1885-7. doi: 10.1055/s-0028-1110360.
7
[Substitution treatment in hemophilia. Critical measures and complications].
Wien Med Wochenschr. 1977 Jun 10;127(11):329-37.
8
[Treatment of hemophilia].
Tidsskr Nor Laegeforen. 1970 Jul 1;90(13):1413-8.
9
Specific therapy in hemophilia.
N C Med J. 1973 Mar;34(3):193-6.
10
Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
JAMA. 1968 Sep 16;205(12):819-21.
引用本文的文献
1
Coagulation factor analysis in patients on long-term anticoagulation.
Calif Med. 1970 Mar;112(3):1-7.
Zotero 插件